Abstract:A versatile oncolytic nanoplatform (Spi‐Mn/MoOx CPs) is designed, drawing inspiration from the delicate physicochemical structure and potent bioactivity of native oncolytic viruses. This nanoplatform effectively ameliorates tumor immune suppression and expedites the antitumor immune responses while sparing healthy tissue, thus presenting a new biomimetic idea to address conundrums in clinical oncolytic therapy. The approval of oncolytic viruses as antigen‐agnostic cancer vaccines provides a paradigm shift for immunotherapy. However, a delicate balance between safety and immunogenicity whether native or engineered oncolytic viruses remains elusive and further compounded by oncolysis‐induced immunosuppression. To address these dilemmas, the de novo design and synthesis of oncolytic viruses‐inspired nanoplatform are proposed by emulating desirable nanostructure and bioactivity for effective cancer immunotherapy. Initially, the influence of MoOx nanoparticles with varying physical morphologies on siRNA transfection are explored, wherein the virus‐inspired MoOx nanoparticles with spiky surfaces (Spi‐MoOx) are well positioned to serve as siRNA vectors to present the highest transfection efficacy. Given the preexisting immune suppression, defect engineering is incorporated into Spi‐MoOx through Mn dopants (Spi‐Mn/MoOx), in an effort to participate in tumor adaptation to hypoxia and maximize the oncolytic potency, while retaining favorable safety profiles. More importantly, the engineered oncolytic viruses hold considerable promise to function as a universal platform that enables any gene to be modulated precisely, allowing the selective activation of various pathways. Collectively, the study offers insights into the biomimetic synthesis and bioactivity of biological system through manipulating the physicochemical cues, while carrying significant implications to propel artificial oncolytic agents from the laboratory to clinical settings.

Macrophage-derived Biomimetic Nanoparticles for Light-Driven Theranostics Toward Mpox

Aggregation-Induced Emission-Based Macrophage-Like Nanoparticles for Targeted Photothermal Therapy and Virus Transmission Blockage in Monkeypox

Combination of GNRs-PEI/cGAMP-laden Macrophages-Based Photothermal Induced in Situ Tumor Vaccines and Immune Checkpoint Blockade for Synergistic Anti-Tumor Immunotherapy.

Breaking Barriers: Current Advances and Future Directions in Mpox Therapy

Macrophage Membrane‐Camouflaged aie Nanoparticles Enhance Photodynamic‐Immunotherapy to Delay Postoperative Tumor Recurrence

Hypoxia Alleviated and One Photo-Triggered Thermal/Dynamic Nanoplatform for Immunogenic Cell Death-Initiated Cancer Immunotherapy

Photothermal Therapy of Tuberculosis Using Targeting Pre-Activated Macrophage Membrane-Coated Nanoparticles

Physicochemical Cues Steering Spiky Mn/MoOx Nanocarriers to Mimic Oncolytic Virus for Potentiating Cancer Immunotherapy

Design of Mitoxantrone‐Loaded Biomimetic Nanocarrier with Sequential Photothermal/Photodynamic/Chemotherapy Effect for Synergized Immunotherapy

Smart Nanovesicle-Mediated Immunogenic Cell Death Through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.

Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy

Precision Delivery of Dual Immune Inhibitors Loaded Nanomodulator to Reverse Immune Suppression for Combinational Photothermal-Immunotherapy

Mpox (formerly monkeypox): pathogenesis, prevention, and treatment

"Butterfly-effect" nano-platforms for cascade immune amplification and tumor clearance through multi-modal therapy and immune sensitization

Development of MOF “Armor‐Plated” Phycocyanin and Synergistic Inhibition of Cellular Respiration for Hypoxic Photodynamic Therapy in Patient‐Derived Xenograft Models

A Multifunctional Nanoamplifier with Self-Enhanced Acidity and Hypoxia Relief for Combined Photothermal/photodynamic/starvation Therapy.

A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy

Mpox treatment evolution: past milestones, present advances, and future directions

Combining Photothermal Therapy‐Induced Immunogenic Cell Death and Hypoxia Relief‐Benefited M1‐Phenotype Macrophage Polarization for Cancer Immunotherapy

Natural Killer Cell Membrane Doped Supramolecular Nanoplatform with Immuno-Modulatory Functions for Immuno-Enhanced Tumor Phototherapy

Fabrication of methylene blue-loaded ovalbumin/polypyrrole nanoparticles for enhanced phototherapy-triggered antitumour immune activation